del(7q) in chronic B-cell lymphoid malignancies

Area of Science:

• Hematology
• Cytogenetics
• Oncology

Background:

• Mature B-cell lymphoproliferative disorders represent a heterogeneous group of lymphoid neoplasms.
• The 7q deletion (del[7q]) is a cytogenetic abnormality observed in various hematologic malignancies.
• Understanding the specific subtypes associated with del[7q] is crucial for accurate diagnosis and prognosis.

Purpose of the Study:

• To characterize the clinical, cytogenetic, and molecular features of B-cell non-Hodgkin's lymphoma/leukemia with del[7q].
• To identify the specific mature B-cell neoplasms associated with this chromosomal deletion.
• To explore potential molecular alterations in these cases.

Main Methods:

• Retrospective analysis of twelve patients diagnosed with B-cell non-Hodgkin's lymphoma/leukemia and del[7q].
• Clinical data review, cytogenetic analysis (karyotyping), and molecular investigations (gene rearrangement analysis).
• Morphological and immunological classification of lymphoma subtypes.

Main Results:

• Eleven patients had small cell lymphoma, one had diffuse large cell lymphoma.
• Lymphoplasmacytic features were present in six of eleven small cell lymphomas.
• Common subtypes included chronic lymphocytic leukemia, marginal zone lymphoma, and mantle cell lymphoma.
• Peripheral blood and bone marrow involvement was observed in eleven patients.
• Two distinct del[7q] types were identified: del(7)(q21q31) and del(7)(q31q34).
• Molecular analysis showed no BCL2, BCL3, or BCL6 involvement; one case had BCL1 rearrangement.

Conclusions:

• The del[7q] abnormality is associated with a subset of mature small B-cell lymphoproliferative disorders.
• These disorders can exhibit lymphoplasmacytic features, but not invariably.
• The findings contribute to the understanding of the spectrum of B-cell neoplasms characterized by del[7q].